GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » Dividend Yield %

Hubei Guangji Pharmaceutical Co (SZSE:000952) Dividend Yield % : 0.00% (As of Jan. 19, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co Dividend Yield %?

As of today (2025-01-19), the Trailing Annual Dividend Yield of Hubei Guangji Pharmaceutical Co is 0.00%.

The historical rank and industry rank for Hubei Guangji Pharmaceutical Co's Dividend Yield % or its related term are showing as below:

During the past 13 years, the highest Dividend Yield of Hubei Guangji Pharmaceutical Co was 1.16%. The lowest was 0.61%. And the median was 0.80%.

SZSE:000952's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.9
* Ranked among companies with meaningful Dividend Yield % only.

Hubei Guangji Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Hubei Guangji Pharmaceutical Co was 0.71. The lowest was 0.17. And the median was 0.41.

As of today (2025-01-19), the Forward Dividend Yield % of Hubei Guangji Pharmaceutical Co is 0.00%.

Hubei Guangji Pharmaceutical Co's Dividends per Share for the three months ended in Sep. 2024 was ¥0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hubei Guangji Pharmaceutical Co was -13.30% per year. The lowest was -13.30% per year. And the median was -13.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Hubei Guangji Pharmaceutical Co Dividend Yield % Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co Dividend Yield % Chart

Hubei Guangji Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.78 0.77 0.78 -

Hubei Guangji Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hubei Guangji Pharmaceutical Co's Dividend Yield %

For the Drug Manufacturers - General subindustry, Hubei Guangji Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Guangji Pharmaceutical Co's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Guangji Pharmaceutical Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Hubei Guangji Pharmaceutical Co's Dividend Yield % falls into.



Hubei Guangji Pharmaceutical Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Hubei Guangji Pharmaceutical Co  (SZSE:000952) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Hubei Guangji Pharmaceutical Co Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Hubei Guangji Pharmaceutical Co's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Guangji Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Jiangdi Road, Hubei, Wuxue, CHN, 435400
Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.
Executives
Zou Guang Ming Independent director
Guo Shao Zhi Executives
Zhang Bin Director
Guo Wen Chao Supervisors
Sun Zhen Hua Director
Liao Qing Jiang Director
Wang Xin Directors, executives
Hu Feng Lei Supervisors
Ruan Zhong Yi Executives
Zhang Ping Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines